88
Growth Score
pts
Heat Score
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3687600
Sanoderm develops topical nanomedicines and dermatology drug candidates for fungal and inflammatory skin conditions.
About the Company
Sanoderm develops clinical-stage dermatology therapies based on a proprietary nanopolymer drug delivery platform. The company focuses on topical nanomedicines designed to treat common and chronic skin disorders, including fungal nail disease, athlete’s foot, and atopic dermatitis. Its work includes internal drug discovery, formulation, and clinical
development of topical products that enhance delivery of active drugs into infected or inflamed skin and nail tissues. Sanoderm collaborates with academic institutions, industry partners, and specialist outsourcing providers to progress its pipeline. Lead candidate BB2603 is in Phase 2b clinical trials and targets localized fungal and inflammatory dermatological conditions.
